Work

A first-in-human phase 1 clinical trial of INI-4001, a novel TLR7/8 agonist, in patients with advanced solid tumors.

Year: 2025

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.tps2703

Authors: Shannon Marilee Miller, Prachi Bhave, Ganessan Kichenadasse, Joseph Sulovski, Jon Ruckle

Institutions: The University of Melbourne, Peter MacCallum Cancer Centre

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410811598

FWCI:

Cites:

Cited by:

Related to: 10